Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
Partner Content Partner Content Pain Therapeutics: Interviews AstraZeneca, Ensysce Bioscienc... Pain Therapeutics Exclusive Speaker Interviews Released
News 23andMe founder isn't giving up her bid to regain control 23andMe founder Anne Wojcicki is hoping to make a fresh bid for the genetic testing firm, riding out a takeover deal with Regeneron.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
